Who are Adenovite's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Yondelis, Yondelis, Adenocard, Tinosorb S, Arbutyne, Regadenoson.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/adenosine-phosphate.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

Adenovite — Competitive Intelligence Brief

Adenovite (ADENOSINE PHOSPHATE) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Adenosine Receptor Agonist. Area: Respiratory.

marketed Adenosine Receptor Agonist Proto-oncogene tyrosine-protein kinase Src Respiratory Small molecule Live · refreshed every 30 min

Target snapshot

Adenovite (ADENOSINE PHOSPHATE).

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Adenovite TARGET	ADENOSINE PHOSPHATE		marketed	Adenosine Receptor Agonist	Proto-oncogene tyrosine-protein kinase Src
Yondelis	TRABECTEDIN	Janssen Prods	marketed	Alkylating Drug [EPC]	Proto-oncogene tyrosine-protein kinase Src	2015-01-01
Yondelis	Yondelis	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	marketed		Proto-oncogene tyrosine-protein kinase Src, Nuclear receptor subfamily 1 group I member 2
Adenocard	ADENOSINE	Astellas Pharma	marketed	Adenosine Receptor Agonist [EPC]	Adenosine receptor A3	1989-01-01
Tinosorb S	BEMOTRIZINOL		marketed	Adenosine Receptor Agonist [EPC]
Arbutyne	ARBUTIN		marketed	Adenosine Receptor Agonist [EPC]	Tyrosinase, Polyphenol oxidase 2, Tyrosinase
Regadenoson	Regadenoson	Pfizer Inc.	marketed	Adenosine receptor agonist	A2A adenosine receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Adenosine Receptor Agonist class)

· 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Adenovite — Competitive Intelligence Brief. https://druglandscape.com/ci/adenosine-phosphate. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab